Introduction
============

Cadmium (Cd), a heavy metal, is present in soils, sediments, air, and water. Unlike most metals, Cd use began fairly recently with its large-scale application dating from 1940s. Today its main uses are for nickel--cadmium battery manufacture, pigments, and plastic stabilizers (WHO, [@B58]).

Cadmium in soil and water is taken up by plants and is concentrated and transferred to upper links of the food chain, including humans (WHO, [@B58]; Satarug et al., [@B50]). Due to the long biological half-life of Cd (i.e., 10--30 years) its accumulation in the body can increase the risk of toxicity (Sugita and Tsuchiya, [@B53]). The principal determinants of human Cd exposure are smoking habits, diet, and to a certain extent, occupational exposure, like that occurring in non-ferrous metal smelters, in the production and processing of Cd alloys and compounds and, increasingly, in the recycling of electronic waste. Non-occupational exposure is mainly from cigaret smoke which contains relatively high concentrations of this element. According to WHO (Wakabayashi et al., [@B57]) one cigaret (containing 0.5--3 μg Cd/g of tobacco) can result in up to 3 μg daily Cd absorption via the lungs. Chronic exposure to these low doses of Cd causes neuroendocrine and neurobehavioral disturbances in animals and humans (Viaene et al., [@B56]; Lafuente et al., [@B29], [@B27], [@B28]; Leret et al., [@B31]).

At a high concentration Cd increases oxidative damage in the rodent brain (Lopez et al., [@B36]; Yang et al., [@B61]). Less information is available on the mediation by redox mechanisms of brain effects of a low concentration of Cd. In a recent study we examined the effect of a low dose of Cd (7.5 μg/day) on 24-h changes in expression of redox pathway enzyme and circadian genes in rat medial basal hypothalamus (MBH; Jiménez-Ortega et al., [@B25]). In CdCl~2~-treated rats a disruption of 24-h pattern of MBH gene expression of nitric oxide synthase (NOS)-1 and -2, heme oxygenase (HO)-1 and -2, Mn-superoxide dismutase (Mn-SOD), catalase, glutathione peroxidase (GPx), and glutathione reductase (GSR) was detectable. Mean 24-h levels of MBH mRNA for HO-2, Mn-SOD, and catalase augmented after Cd intake (presumably as a compensatory increase caused by the augmented oxidative load), whereas those of NOS-2 decreased (presumably because Cd causes toxicity independently of NO formation; Wright and Baccarelli, [@B60]). After CdCl~2~ intake, the 24-h pattern of clock gene expression in MBH seen in control rats was significantly disrupted, suggesting that a primary mechanism of action could be on circadian clock mechanisms (Jiménez-Ortega et al., [@B25]).

Melatonin, the major secretory product of the pineal gland, is released every day at night. In addition, melatonin is also locally synthesized in various cells, tissues, and organs including lymphocytes, human and murine bone marrow, the thymus, the gastrointestinal tract, skin, and the eyes where it plays either an autocrine or paracrine role (see for reference, Pandi-Perumal et al., [@B41]; Reiter et al., [@B44]; Hardeland et al., [@B18]). Both in animals and in humans, melatonin participates in diverse physiological functions signaling not only the length of the night (the chronobiotic effect; Dawson and Armstrong, [@B11]; Arendt and Skene, [@B2]) but also enhancing free radical scavenging, the immune response and cytoprotection (Hardeland et al., [@B18]).

The objective of the present study was to examine the putative chronobiotic--cytoprotective role of melatonin on Cd-induced changes in clock gene and redox enzyme gene expression in rat MBH. We also wished to assess whether the concomitant administration of melatonin could modify 24-h expression of MBH redox enzyme genes in a way compatible with the recently reported activity of melatonin on the same set of enzymes (Jiménez-Ortega et al., [@B24]).

Materials and Methods
=====================

Animals and experimental design
-------------------------------

Male Wistar rats (45 days of age, *n* = 169) were maintained under standard conditions with controlled light (12:12 h light/dark schedule; lights on at 0800 h) and temperature (22 ± 2°C). The rats received CdCl~2~ (5 ppm) and melatonin (3 μg/mL) or vehicle in drinking water for 1 month. Two groups given melatonin or vehicle in tap water were also included. Food and water were supplied *ad libitum*. The stock solution of melatonin was prepared in 50% ethanol; final ethanol concentration in drinking water was 0.015%. Cd-administered animals and vehicle-treated controls received 0.015% ethanol in drinking water. Since rats drank about 20 mL/day with 90--95% of this total daily water taken up during the dark period, the melatonin dosage used provided approximately 60 μg melatonin/day. This dose was 10 timed higher than that needed to obtain physiological circulating melatonin levels in pinealectomized rats (Cardinali et al., [@B7]). Nocturnal water consumption did not differ among the experimental groups.

After 1 month groups of six to eight rats were sacrificed by decapitation under conditions of minimal stress at six different time intervals, every 4 h throughout a 24-h cycle, starting at 0900 h. At night intervals animals were killed under red dim light. The brains were rapidly removed and the MBH including the median eminence was quickly dissected out following the landmarks of Szentagothai et al., [@B54]. The MBH consisted of a 3-mm-thick block of tissue weighing 4--6 mg and extending from the rostral border of the optic chiasm to the rostral margin of the mammillary bodies, and laterally to the hypothalamic sulci (Moreno et al., [@B40]).

Samples were kept frozen at −70°C until further assayed. The care and use as well as all procedures involving animals were approved by the Institutional Animal Care Committee, Faculty of Medicine, Complutense University, Madrid. The study was in accordance with the guidelines of the Institutional Care and Use Committee of the National Institute on Drug Abuse, National Institutes of Health and the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, [@B22]).

Real-time quantitative polymerase chain reaction
------------------------------------------------

Total RNA extraction was performed using the RNeasy protect mini kit and was analyzed using QuantiTec SYBR green kit (Qiagen, Hielden, Germany). The iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories SA, Madrid) was used to synthesize cDNA from 1 μg of total RNA, according to the manufacturer's protocol. The house keeping gene β-actin was used as a constitutive control for normalization.

Reactions were carried out in the presence of 200 nM of specific primers for *Clock*, *Bmal1, Per1*, *Per2*, *Cry1*, and *Cry2*, NOS-1, NOS-2, HO-1, HO-2, Cu/Zn-SOD, Mn-SOD, catalase, GPx, and GSR. Primers were designed using Primer3 software (The Whitehead Institute, <http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi>) and are shown in Table [1](#T1){ref-type="table"}.

###### 

**Sequence of the primers used for real-time PCR**.

  Gene                   Primers                      Product size (bp)
  ----------- ---------- ---------------------------- -------------------
  β-Actin     Forward    ctctcttccagccttccttc         99
              Backward   ggtctttacggatgtcaacg         
  Clock       Forward    tgccagctcatgagaagatg         98
              Backward   catcgctggctgtgttaatg         
  Bmal1       Forward    ccgtggaccaaggaagtaga         102
              Backward   ctgtgagctgtgggaaggtt         
  Per1        Forward    ggctccggtacttctctttc         106
              Backward   aataggggagtggtcaaagg         
  Per2        Forward    acacctcatgagccagacat         99
              Backward   ctttgactcttgccactggt         
  Cry1        Forward    cagttgcctgtttcctgacc         91
              Backward   cagtcggcgtcaagcagt           
  Cry2        Forward    attgagcggatgaagcagat         103
              Backward   ccacagggtgactgaggtct         
  NOS-1       Forward    atcggcgtccgtgactactg         92
              Backward   tcctcatgtccaaatccatcttcttg   
  NOS-2       Forward    tggcctccctctggaaaga          93
              Backward   ggtggtccatgatggtcacat        
  HO-1        Forward    tgctcgcatgaacactctg          123
              Backward   tcctctgtcagcagtgcc           
  HO-2        Forward    agcaaagttggccttaccaa         84
              Backward   gtttgtgctgccctcacttc         
  Cu/Zn-SOD   Forward    ggtggtccacgagaaacaag         98
              Backward   caatcacaccacaagccaag         
  Mn-SOD      Forward    aaggagcaaggtcgcttaca         94
              Backward   acacatcaatccccagcagt         
  Catalase    Forward    gaatggctatggctcacaca         100
              Backward   caagtttttgatgccctggt         
  GPx1        Forward    tgcaatcagttcggacatc          120
              Backward   cacctcgcacttctcaaaca         
  GSR         Forward    atcaaggagaagcgggatg          96
              Backward   gcgtagccgtggatgactt          

Polymerase chain reactions (PCR) were carried out in an Eppendorf RealPlex Mastercycler (Eppendorf AG, Hamburg, Germany). The real-time quantitative PCR (qPCR) program included a 94°C enzyme activation step for 2 min followed by 40 cycles of 95°C denaturation for 15 s, 60°C annealing for 30 s and 72°C extension for 30 s. Detection of fluorescent product was carried out at the end of the 72°C extension period.

Serial dilutions of cDNA from control MBH were used to perform calibration curves in order to determine amplification efficiencies. For the primers used there were no differences between transcription efficiencies, the amount of initial cDNA in each sample being calculated by the 2^−ΔΔCt^ method (Livak and Schmittgen, [@B35]). All samples were analyzed in triplicate and in three different measures. Fractional cycle at which the amount of amplified target becomes significant (Ct) was automatically calculated by the PCR device.

To estimate whether treatment or time of day modified the expression of β-actin, in MBH PCR with serial dilutions of this housekeeping gene was performed. In this study Ct did not vary significantly as a function of treatment or of time of day, indicating the validity to employ β-actin as a housekeeping gene. It must be noted that in a previous study on β-actin expression in a larger hypothalamic block than that used herein, which weighed 42--63 mg and included the preoptic, suprachiasmatic, paraventricular, supraoptic, arcuate, dorsomedial, ventromedial, and mammillary areas and the median eminence revealed time of day changes with maxima at 0800 h (Iovanna et al., [@B23]).

Data analysis
-------------

After verifying normality of distribution of data in a normal distribution probability plot, the statistical analysis of the results was performed by a one-way or a two-way factorial analysis of variance (ANOVA) followed by Bonferroni's multiple comparison tests, as stated. *P* values lower than 0.05 were considered evidence for statistical significance.

Results
=======

The effect of Cd and/or melatonin on 24-h pattern of MBH mRNA levels of the circadian clock genes examined is depicted in Figure [1](#F1){ref-type="fig"}. In control rats, MBH mRNA levels of *Bmal1* attained maximal values at the beginning of scotophase followed by a nadir at the middle of the phase and a second increase at the end (*p* \< 0.01). MBH *Per1* expression peaked at later afternoon during photophase (*p* \< 0.01) while *Cry2* expression showed maxima during the scotophase (*p* \< 0.03). Two maxima (at the middle of photophase and at the beginning and middle of scotophase) were seen in the case of mRNA *Per2* levels (*p* \< 0.01; Figure [1](#F1){ref-type="fig"}). Neither *Clock* nor *Cry1* expression exhibited significant 24-h variations.

![**Effect of melatonin on Cd-induced changes in 24-h pattern in expression of *Clock*, *Bmal1*, *Per1*, *Per2, Cry1*, and *Cry2* in rat MBH**. The rats received CdCl~2~ (5 ppm) and melatonin (3 μg/mL) or vehicle in drinking water for 1 month. Two groups given melatonin or vehicle in tap water were also included. Groups of six to eight rats were killed by decapitation at six different time intervals throughout a 24-h cycle. mRNA levels encoding the clock genes were measured as described in the text. Shown are the mean ± SEM of mRNA determination as measured by triplicate real-time PCR analyses of RNA samples. Letters denote significant differences in a one-way ANOVA followed by a Bonferroni's multiple comparison test performed at every time interval, as follows: ^a^*p* \< 0.05 vs. Cd and melatonin groups; ^b^*p* \< 0.02 vs. Cd and Cd + melatonin groups; ^c^*p* \< 0.05 vs. Cd; ^d^*p* \< 0.01 vs. the remaining groups; ^e^*p* \< 0.01 vs. Cd and control groups; ^f^*p* \< 0.05 vs. control. One-way ANOVAs within each experimental group indicated significant time-related changes in clock gene expression as follows: Controls: *Bmal1*, *Per1*, *Per2*, and *Cry2* (*F* = 11.3, *p* \< 0.0001, *F* = 2.54, *p* \< 0.04, *F* = 7.94, *p* \< 0.001, and *F* = 3.41, *p* \< 0.03, respectively). Cd: *Clock*, *Per1*, *Per2*, and *Cry2* (*F* = 4.71, *p* \< 0.008, *F* = 4.12, *p* \< 0.01, *F* = 5.84, *p* \< 0.03, and *F* = 19.1, *p* \< 0.0001, respectively). Cd + melatonin: *Bmal1*, *Per1*, *Per2, Cry1*, and *Cry2* (*F* = 10.1, *p* \< 0.0001, *F* = 3.11, *p* \< 0.04, *F* = 4.48, *p* \< 0.009, *F* = 7.82, *p* \< 0.001, and *F* = 19.6, *p* \< 0.0001, respectively. Melatonin: *Per2* and *Cry2* (*F* = 14.2 and 50.8, *p* \< 0.0001, respectively). For further statistical analysis, see text.](fneur-02-00013-g001){#F1}

CdCl~2~ treatment significantly suppressed circadian rhythmicity in *Bmal1* expression, changed the phase of *Per1*, *Per2*, and *Cry2* expression and induced a late photophase peak in *Clock* expression (*p* \< 0.01). The concomitant administration of melatonin counteracted the changes in 24-h pattern of *Per1* expression caused by Cd, whereas it did not affect significantly other changes found with Cd (as for *Clock, Per2*, and *Cry2* expression) or induced new maxima (as for *Bmal1* or *Cry1* expression; Figure [1](#F1){ref-type="fig"}). In animals receiving melatonin alone the 24-h pattern in expression of MBH *Per2* and *Cry2* was significantly disrupted (*p* \< 0.01), while that of *Clock*, *Bmal1*, *Per1*, and *Cry1* remained unchanged (Figure [1](#F1){ref-type="fig"}).

Figures [2](#F2){ref-type="fig"} and [4](#F4){ref-type="fig"} summarize the effect of treatment on 24-h pattern and mean levels of MBH mRNA of the redox enzymes examined. Control rats exhibited significant daily variations in MBH expression of Cu/Zn-SOD, Mn-SOD, catalase, GPx, NOS-2, HO-1, and HO-2 genes (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). CdCl~2~ administration phase-delayed Mn-SOD gene expression and suppressed the maximum in gene expression of GPx seen at midday (*p* \< 0.03; Figure [2](#F2){ref-type="fig"}). CdCl~2~ also affected the 24-h pattern of expression of MBH NOS and HO isoenzymes by inducing maxima at late scotophase (NOS-1), at midday and late scotophase (NOS-2), at midday, early and late scotophase (HO-1), and at early morning (HO-2; Figure [3](#F3){ref-type="fig"}).

![**Effect of melatonin on Cd-induced changes in 24-h pattern in expression of mRNA for Cu/Zn-SOD, Mn-SOD, catalase, Gpx, and GSR in rat MBH**. For experimental details see legend to Figure [1](#F1){ref-type="fig"}. mRNA levels encoding the enzymes were measured as described in the text. Shown are the mean ± SEM of mRNA determination as measured by triplicate real-time PCR analyses of RNA samples. Letters denote significant differences in a one-way ANOVA followed by a Bonferroni's multiple comparison test performed at every time interval, as follows: ^a^*p* \< 0.02 vs. Cd and control groups; ^b^*p* \< 0.05 vs. melatonin and control groups; ^c^*p* \< 0.01 vs. the remaining groups; ^d^*p* \< 0.05 vs. melatonin and Cd groups; ^e^*p* \< 0.05 vs. melatonin and control groups; ^f^*p* \< 0.05 vs. the remaining groups; ^g^*p* \< 0.01 vs. Cd; ^h^*p* \< 0.02 vs. control; One-way ANOVAs within each experimental group indicated significant time-related changes in enzyme gene expression as follows: Controls: Cu/Zn-SOD, Mn-SOD, catalase, and GPx (*F* = 6.21, *p* \< 0.002, *F* = 3.33, *p* \< 0.03, *F* = 3.17, *p* \< 0.04, and *F* = 2.98, *p* \< 0.04, respectively). Cd: Cu/Zn-SOD and Mn-SOD (*F* = 6.25, *p* \< 0.002, and *F* = 7.01, *p* \< 0.001, respectively). Cd + melatonin: Cu/Zn-SOD, Mn-SOD, catalase, and GSR (*F* = 14.1, *p* \< 0.0001, *F* = 15.5, *p* \< 0.0001, *F* = 10.8, *p* \< 0.0001, and *F* = 8.24, *p* \< 0.0001, respectively). Melatonin: Mn-SOD, catalase, GPx, and GSR (*F* = 4.49, *p* \< 0.002, *F* = 2.46, *p* \< 0.05, *F* = 15.9, *p* \< 0.0001, and *F* = 8.35, *p* \< 0.0001, respectively). For further statistical analysis, see text.](fneur-02-00013-g002){#F2}

![**Effect of melatonin on Cd-induced changes in 24-h pattern of expression of mRNA for NOS-1, HO-1, NOS-2, and NOS-2 in rat MBH**. For experimental details see legend to Figure [1](#F1){ref-type="fig"}. mRNA levels encoding the enzymes were measured as described in the text. Shown are the mean ± SEM of mRNA determination as measured by triplicate real-time PCR analyses of RNA samples. Letters denote significant differences in a one-way ANOVA followed by a Bonferroni's multiple comparison test performed at every time interval, as follows: ^a^*p* \< 0.05 vs. Cd + melatonin group; ^b^*p* \< 0.05 vs. the remaining groups; ^c^*p* \< 0.02 vs. Cd; ^d^*p* \< 0.02 vs. control and Cd groups; ^e^*p* \< 0.01 vs. the remaining groups; ^f^*p* \< 0.02 vs. control and Cd + melatonin groups; ^g^*p* \< 0.01 vs. control; ^h^*p* \< 0.01 vs. melatonin. One-way ANOVAs within each experimental group indicated significant time-related changes in enzyme gene expression as follows: Controls: HO-1, NOS-2, and HO-2 (*F* = 7.54, *p* \< 0.001, *F* = 10.1, *p* \< 0.0001, and *F* = 5.64, *p* \< 0.002, respectively). Cd: NOS-1, HO-1, NOS-2, and HO-2 (*F* = 5.88, *p* \< 0.002, *F* = 8.41, *p* \< 0.0001, *F* = 18.3, *p* \< 0.0001, and *F* = 7.42, *p* \< 0.001, respectively). Cd + melatonin: HO-1, NOS-2, and HO-2 (*F* = 8.45, *p* \< 0.0001, *F* = 6.12, *p* \< 0.002, and *F* = 4.04, *p* \< 0.03, respectively). Melatonin: NOS-1, NOS-2, and HO-1 (*F* = 10.7, *p* \< 0.0001, 12.9, *p* \< 0.0001, and 5.92, *p* \< 0.004, respectively). For further statistical analysis, see text.](fneur-02-00013-g003){#F3}

![**Effect of melatonin on Cd-induced changes in mRNA of redox enzymes in rat MBH**. Shown are the mean 24 h values ± SEM. For experimental details see legend to Figure [1](#F1){ref-type="fig"}. Letters denote significant differences in a one-way ANOVA followed by a Bonferroni's multiple comparison as follows: ^a^*p* \< 0.01 vs. control and Cd groups; ^b^*p* \< 0.05 vs. control; ^c^*p* \< 0.02 vs. control; ^d^*p* \< 0.02 vs. the remaining groups; ^e^*p* \< 0.02 vs. control and Cd groups; ^f^*p* \< 0.03 vs. the remaining groups.](fneur-02-00013-g004){#F4}

The concomitant administration of melatonin reversed the phase delay in Mn-SOD gene expression given by CdCl~2~ (*p* \< 0.001; Figure [2](#F2){ref-type="fig"}) and counteracted the effect of Cd on 24 h pattern in expression of NOS and HO isoenzymes (*p* \< 0.02; Figure [3](#F3){ref-type="fig"}). Melatonin + CdCl~2~ administration disrupted the 24-h pattern of Cu/Zn-SOD gene expression by inducing a late scotophase peak (*p* \< 0.02; Figure [2](#F2){ref-type="fig"}). In animals receiving melatonin alone, suppression of 24-h rhythmicity in gene expression (Cu/Zn-SOD, HO-2) and induction of a mid-scotophase (GSR) or early morning peak of expression (NOS-1, NOS-2, HO-1) were found (*p* \< 0.01; Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

Figure [4](#F4){ref-type="fig"} depicts the mean 24-h values for gene expression of MBH redox enzymes in the four groups of animals studied. A factorial ANOVA on the effects of treatment on mean gene expression indicated that CdCl~2~ administration increased significantly Mn-SOD, catalase, and HO-2 expression and decreased that of NOS-2 gene. The concomitant administration of melatonin reversed the effect of Cd on mean catalase, NOS-2, and HO-2 gene expression, augmented 24-h mean values of Cu/Zn- and Mn-SOD mRNA levels and decreased those of GPx, GSR, and HO-1. In animals receiving melatonin alone, significant increases in mean Cu/Zn and Mn-SOD gene expression, and decreases in that of GPx, GSR, NOS-1, NOS-2, HO-1, and HO-2, were found (Figure [4](#F4){ref-type="fig"}).

Discussion
==========

The mammalian circadian timing system comprises oscillators found in almost every cell of the body together with a central rhythm generator located in the hypothalamic suprachiasmatic nuclei (SCN; Lincoln et al., [@B34]). At the cell level, circadian rhythms are driven by the self-regulatory interaction of a set of clock genes and their protein products (Levi et al., [@B32]). The positive drive to the daily clock is constituted by helix-loop-helix, PAS-domain containing transcription factor genes, called *Clock* and *Bmal1* (or its paralog *Npas2*). The protein products of these genes form heterodimeric complexes that control the transcription of other clock genes, notably Period (*Per1*/*Per2/Per3*) genes, and Cryptochrome (*Cry1*/*Cry2*) genes, which in turn provide the negative feedback signal that shuts down the *Clock*/*Bmal1* drive to complete the circadian cycle. Other clock genes like *Rev-erb*α, *Ror*α, *NR1D1*, or *timeless* provide additional transcriptional/translational feedback loops to form the rest of the core clockwork (Levi et al., [@B32]), which has been characterized in rodents by a transgenic gene deletion methodology.

A major question concerns as about how the circadian apparatus is adjusted to maintain coordination between physiology and the changing environment. Models including the relation between the redox state and the circadian clockwork have been proposed (Rutter et al., [@B48]). In zebrafish, light, as a key entraining stimulus for the circadian clock, induces the production of hydrogen peroxide that acts as the second messenger coupling photoreception to the circadian clock, as shown by the induction of *zCry1a* and *zPer2* genes and the subsequent circadian oscillation of *zPer1*. In Z3 cells (Hirayama et al., [@B20]). These findings support a link between the regulation circadian clock genes and the control of cellular redox state (Rutter et al., [@B48]).

The present study aimed to examine the relations between circadian clock gene expression and gene expression of redox enzymes in a complex, heterogeneous brain area like the MBH of rats receiving a low dose of CdCl~2~ and/or melatonin. In the MBH of control rats expression of *Bmal1* peaked at early scotophase, *Per1* at late afternoon, and *Per2* and *Cry2* at mid-scotophase, whereas neither *Clock* nor *Cry1* expression showed significant 24-h variations. Presumably, the nuclear heterogeneity of the MBH fragments employed precluded identification of the reciprocal relationship between *Clock/Bmal1* and *Per1/Per2* expression seen in isolated nuclei, like the SCN (Poirel et al., [@B43]; Agez et al., [@B1]; Challet, [@B9]).

As shown previously (Jiménez-Ortega et al., [@B25]), a low amount of CdCl~2~ (i.e., 5 ppm in tap water, about 7.5 μg/day) significantly suppressed (*Bmal1*) or disrupted 24-h pattern of expression (*Per1*, *Per2, Cry2*) while in the case of *Clock* significant 24-h variations were induced. The results suggest that the inherent transcription modifications that give the clock its own natural rhythmicity are disrupted in rats drinking a low amount of CdCl~2~ in tap water. Previous studies from this laboratory indicated that chronic exposure of rats to similar low doses of Cd affected the circadian variation of pituitary hormone release (Lafuente et al., [@B29], [@B27], [@B28]). It seems feasible that the changes in clock gene expression in MBH, a key region in hormone regulation, play a role in the circadian hormone disruption.

In the present study, the concomitant administration of melatonin (3 μg/mL; a chronobiotic--cytoprotective agent; Hardeland et al., [@B18]) in drinking water failed to counteract most effects of Cd on clock genes, except for *Per1* expression. This suggests that the transcription modifications through which CdCl~2~ administration disrupts the natural rhythmicity of the circadian clock are only slightly affected by melatonin administration. A survey of the scientific literature supports an effect of melatonin on circadian clock components in the mammalian SCN (Poirel et al., [@B43]; Agez et al., [@B1]; Challet, [@B9]), retina (Dinet and Korf, [@B14]; Dinet et al., [@B13]), and striatal neurons in culture (Imbesi et al., [@B21]). In the present study, animals receiving melatonin alone showed significant phase-advances in MBH *Per2* and *Cry2* expression to peak at late afternoon and early scotophase, respectively. Again, the nuclear heterogeneity of the MBH fragments makes it impossible any valid comparison with the published effects on melatonin activity in isolated brain nuclei.

As an indication of the link between the redox status and the circadian system, 24-h variations in brain redox pathway enzymes have been described, including NOS (Ayers et al., [@B4]; Tunctan et al., [@B55]; Clemens et al., [@B10]), HO (Artinian et al., [@B3]; Rubio et al., [@B47]), SOD (Diaz-Munoz et al., [@B12]; Schaper et al., [@B51]; Martin et al., [@B39]), and catalase (Sani et al., [@B49]). Our present results on the circadian variation in gene expression of NOS and HO in MBH of control rats are consistent with previous publications (Jiménez-Ortega et al., [@B24], [@B25]). In the case of the circadian rhythms in MBH mRNA levels for Cu/Zn- and Mn-SOD and catalase, our previous data partially disagreed with them, e.g., the late afternoon peak in Cu/Zn-SOD gene expression reported herein was only seen in one of our previous studies (Jiménez-Ortega et al., [@B25]) while the late afternoon peak in Mn-SOD was seen only as a trend in the two previous studies (Jiménez-Ortega et al., [@B24], [@B25]).

The administration of low amount of CdCl~2~ brought about significant changes in 24-h variation in gene expression of MBH Cu/Zn-SOD, GPx, GSR, NOS-2, HO-1, and HO-2. The concomitant administration of melatonin prevented most of the effects of Cd on 24-h rhythmicity and overall expression of redox enzyme genes. In particular, the co-administration of melatonin and CdCl~2~, or the administration of melatonin alone, brought about a remarkable increase of Cu/Zn-SOD gene expression. Providing that this did reflect an increased enzyme protein activity, the elevated levels of reduced glutathione expected to occur may explain, by negative feedback regulation (Griffith, [@B17]; Lu, [@B37]), the very significant decrease in MBH mRNA levels for GPx, GSR, and HO-2 found under those conditions. While some metals, like iron, copper, chromium, vanadium, or cobalt undergo redox-cycling reactions, a second group of metals including Cd, mercury, and nickel cause toxicity mainly by depleting glutathione (Wright and Baccarelli, [@B60]). Thus melatonin could be an effective antidote for the toxic effect of this second group of metals.

The doses of Cd employed in the present study may resemble real exposure level in active tobacco smokers, in moderately to heavily polluted areas or under occupational exposure conditions (Brzóska and Moniuszko-Jakoniuk, [@B6]). Under this condition, Cd intake was close to that proposed by the World Health Organization as a tolerable limit for humans \[1 μg/day for a life span of 60 years (1995)\]. It should be noted that because Cd absorption in the gastrointestinal tract of rats is lower than in humans, rat models simulating human exposure need to increase exposure doses to be higher than the real daily human intake of Cd (Rogalska et al., [@B46]).

In the present and a previous study (Jiménez-Ortega et al., [@B25]), a low dose of Cd differentially affects NOS-1 and NOS-2 expression in MBH by disrupting their 24-h pattern and by decreasing the 24-h mean mRNA levels for NOS-2. The neuronal isoform of NOS (NOS-1) is constitutively expressed in neurons whereas expression of the inducible (macrophage) isoform NOS-2 occurs mainly in glial cells (Galea et al., [@B16]) and also in neurons (Wong et al., [@B59]). NOS has been detected in several hypothalamic areas including the SCN (Plano et al., [@B42]) and the supraoptic, paraventricular, ventromedial, and dorsomedial nuclei (Ceccatelli, [@B8]). NOS is also present in fibers at the median eminence, mainly in the internal layer and around blood vessels of the portal system (Knauf et al., [@B26]). The present results reinforce the view that the toxic effect of a low dose of Cd is independent on excessive NO formation. It is interesting that melatonin counteracted the generally inhibitory and disrupting effects of Cd on 24-h pattern of activity of NOS whereas, when administered alone, melatonin decreased gene expression of MBH NOS, as reported previously (Jiménez-Ortega et al., [@B24]) and seen again in the present series of experiments.

Heme oxygenase has an important role in controlling the redox state of the cell by functioning as a rate-limiting enzyme in the heme degradation process (Mancuso et al., [@B38]). Three isoforms of HO have been identified. HO-1 is an inducible isoform that is responsive to various stimuli, including oxidative stress. HO-2 is a constitutive isoform that is highly concentrated in the brain is less inducible by oxidative stress. The remaining isoform, HO-3, has been less well characterized. Various hypothalamic nuclei displayed both HO-1 and HO-2 mRNA proteins (Ewing and Maines, [@B15]) and enzymatic activities (Rubio et al., [@B47]) explaining the high CO production rate that the hypothalamus exhibits (Laitinen and Juvonen, [@B30]). In the present study CdCl~2~ augmented MBH mRNA levels of HO-2 and affected the 24-h pattern of expression of both HO isoenzymes by inducing maxima at midday, early and late scotophase (HO-1), and at early morning (HO-2). The stimulatory effect of CdCl~2~ on HO-2 mRNA reported in the present study can be interpreted in terms of an increased of oxidative load (i.e., more need of HO-1 expression).

The administration of melatonin counteracted significantly the effect of Cd on 24 h pattern in expression of both isoenzymes of HO. As shown earlier (Jiménez-Ortega et al., [@B24]) the inhibitory effect of melatonin on HO-1 and HO-2 mRNA is remarkable. The mechanisms involved in regulation of redox enzyme gene expression by melatonin could involve receptor-mediated and receptor-independent phenomena (Hardeland et al., [@B18]). Among the latter inhibition of radical oxygen species (ROS) generation is attractive. Since ROS play a role in cellular signaling processes, including transcription factors like nuclear factor-κB or activator protein-1, a decrease of free radical production by melatonin would allow the repression of redox-sensitive transcription factors, which could regulate gene transcription (Lezoualc'h et al., [@B33]; Beni et al., [@B5]; Rodriguez et al., [@B45]).

There are a number of limitations to the present descriptive study. One important is that studies employing Western blotting analysis of clock protein levels are further needed to understand Cd--melatonin interactions on circadian clock and redox enzyme gene expression. It should be also important to assess whether the changes in amplitude as well in timing of 24-h rhythm of gene expression discussed herein can be attributed to an effect on the circadian master clock or to a masking effect on some output(s) of the clock. The nuclear heterogeneity of the MBH fragments employed is a feasible explanation for the inability to uncover some the relationships seen between clock genes in isolated brain nuclei.

Summarizing, the results support the conclusion that the interfering effect of melatonin on the activity of a low dose of Cd on 24-h rhythms of MBH clock and redox enzyme genes is mainly exerted at the level of redox enzyme gene expression. Since most of published studies on neuroprotective activity of melatonin were performed by measuring specific targets at single time points, generally at morning hours, and in view of the 24-h changes in redox state that occurs in a number of tissues (Hardeland et al., [@B19]; Subramanian et al., [@B52]), it should be important to include a chronopharmacological approach for the full analysis of the above mentioned effects of melatonin.
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